Whats that in my eye?!
Thirty-three cases of a rare, but serious, fungal eye infection have been confirmed across seven states. Federal officials are announcing that the infection stemmed from products mixed in a Florida compounding pharmacy.
it seems the victims underwent some sort of an eye procedure, either a surgery or injections. Of these, 23 suffered vision loss and 24 needed repeat surgery, according to the AP, citing a report by the U.S. Centers for Disease Control and Prevention (CDC).
According to AP, many cases were traced by health officials to a dye and an injection that included triamcinolone and other products that came from Franck’s Compounding Lab in Ocala, Florida. The U.S. Food & Drug Administration (FDA) tested unopened bottles and unused syringes of the dye collected from Franck’s Compounding Lab and discovered multiple bacterial and fungal species.
CDC officials said the investigation to identify the root cause is ongoing and warned doctors and patients to stay away from “compounded products labeled as sterile from Franck’s,” according to the report.
The FDA is also investigating the matter and has advised that any Brilliant Blue G (BBG) product from Franck’s be quarantined and returned. The FDA stated it received reports of fungal endophthalmitis (eye infections) in patients given BBG supplied by Franck’s Pharmacy during eye surgeries. BBG is not an approved drug in the U.S., noted the FDA.
Related Posts:
[related_posts limit=”5″]